Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports chiral synthesis, making it valuable in creating enantiomerically pure drugs. Commonly employed in medicinal chemistry for building blocks in drug discovery, especially in treatments targeting viral infections and metabolic disorders. The difluorinated pyrrolidine ring enhances metabolic stability and bioavailability in final drug candidates.